Juvenile idiopathic arthritis.
Martini, A; Lovell, DJ; Albani, S; Brunner, HI; Hyrich, KL; Thompson, SD; Ruperto, N.
.
2022.
Alternative Biologic Therapy in Children Failing Conventional TNFα Inhibitors for Refractory, Noninfectious, Chronic Anterior Uveitis.
Miraldi Utz, V; Angeles-Han, ST; Mwase, N; Cassedy, A; Hennard, T; Lovell, DJ; Lopper, S; Brunner, HI; Dosunmu, EO; Grom, AA; et al.
American Journal of Ophthalmology.
2022;
244:183-195.
Intraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry.
Hahn, T; Daymont, C; Groh, B; Hays, K; Bingham, CA; Scalzi, L; Abel, N; Abulaban, K; Adams, A; Adams, M; et al.
Pediatric Rheumatology.
2022;
20.
Childhood‐onset lupus nephritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: Short‐term kidney status and variation in care.
Smitherman, EA; Chahine, RA; Lewandowski, LB; Rahman, AF; Wenderfer, SE; Curtis, JR; Hersh, AO; Abel, N; Abulaban, K; Adams, A; et al.
Arthritis Care and Research.
2022.
Children With Enthesitis-Related Arthritis and Possible Benefits From Treatments for Adults With Spondyloarthritis.
Weiss, PF; Fuhlbrigge, RC; von Scheven, E; Lovell, DJ; Colbert, RA; Brunner, HI.
Arthritis Care and Research.
2022;
74:1058-1064.
POS0340 PREDICTORS OF CLINICAL RESPONSE TO ABATACEPT IN CHILDREN WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS.
Ruperto, N; Brunner, H; Berman, A; Avila Zapata, F; Horneff, G; Wagner-Weiner, L; Belot, A; Burgos-Vargas, R; Gámir Gámir, ML; Goldenstein-Schainberg, C; et al.
Annals of the Rheumatic Diseases.
2022;
81:422.2-42423.
OP0221 EFFICACY OF SECUKINUMAB IN ENTHESITIS-RELATED ARTHRITIS: RESULTS FROM A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, TREATMENT WITHDRAWAL, PHASE 3 STUDY (JUNIPERA).
Ruperto, N; Chertok, E; Dehoorne, J; Horneff, G; Kallinich, T; Louw, I; Compeyrot-Lacassagne, S; Lauwerys, B; Martin, N; Marzan, K; et al.
Annals of the Rheumatic Diseases.
2022;
81:145-146.
Tofacitinib for juvenile idiopathic arthritis - Authors' reply.
Ruperto, N; Brunner, HI; Posner, HB; Lazariciu, I; Martini, A; Lovell, DJ.
The Lancet.
2022;
399.
Consensus Approach to a Treat-to-target Strategy in Juvenile Idiopathic Arthritis Care: Report From the 2020 PR-COIN Consensus Conference.
El Tal, T; Ryan, ME; Feldman, BM; Bingham, CA; Burnham, JM; Batthish, M; Bullock, D; Ferraro, K; Gilbert, M; Gillispie-Taylor, M; et al.
Journal of Rheumatology.
2022;
49:497-503.
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis.
Onel, KB; Horton, DB; Lovell, DJ; Shenoi, S; Cuello, CA; Angeles-Han, ST; Becker, ML; Cron, RQ; Feldman, BM; Ferguson, PJ; et al.
Arthritis Care and Research.
2022;
74:521-537.